Arbutus Biopharma Corporation (FRA:I9DN)
3.650
+0.010 (0.27%)
At close: Nov 26, 2025
Arbutus Biopharma Market Cap
Arbutus Biopharma has a market cap or net worth of €731.44 million as of December 1, 2025. Its market cap has increased by 11.84% in one year.
Market Cap
731.44M
Enterprise Value
654.61M
Revenue
12.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.65
Market Cap Chart
Since November 15, 2010, Arbutus Biopharma's market cap has increased from 53.50M to 731.44M, an increase of 1,267.16%. That is a compound annual growth rate of 18.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 696.49M | 16.37% |
| Dec 31, 2024 | 598.51M | 57.80% |
| Dec 29, 2023 | 379.28M | 11.19% |
| Dec 30, 2022 | 341.13M | -26.27% |
| Dec 31, 2021 | 462.69M | 87.76% |
| Dec 31, 2020 | 246.42M | 60.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |